Comparison of BDPhoenix and VITEK2 automated antimicrobial susceptibility test systems for extended-spectrum beta-lactamase detection in Escherichia coli and Klebsiella species clinical isolates.

scientific article

Comparison of BDPhoenix and VITEK2 automated antimicrobial susceptibility test systems for extended-spectrum beta-lactamase detection in Escherichia coli and Klebsiella species clinical isolates. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0732-8893(02)00481-9
P698PubMed publication ID12573548

P2093author name stringDietrich Mack
Rainer Laufs
Heinz-Hubert Feucht
Ingo Sobottka
Enno Stürenburg
P2860cites workExtended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threatQ24550671
beta-Lactamases in laboratory and clinical resistanceQ24669605
A novel extended-spectrum TEM-type beta-lactamase (TEM-52) associated with decreased susceptibility to moxalactam in Klebsiella pneumoniaeQ33690561
Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.Q33972587
Use of microdilution panels with and without beta-lactamase inhibitors as a phenotypic test for beta-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens.Q33976916
Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcomeQ34106854
Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322Q37592206
Ability of the VITEK 2 advanced expert system To identify beta-lactam phenotypes in isolates of Enterobacteriaceae and Pseudomonas aeruginosa.Q39455190
Automated thermal cycling is superior to traditional methods for nucleotide sequencing of bla(SHV) genes.Q39472406
Antimicrobial susceptibility testing: general principles and contemporary practicesQ41752677
Validation of the VITEK2 and the Advance Expert System with a collection of Enterobacteriaceae harboring extended spectrum or inhibitor resistant beta-lactamases.Q43785356
Cefpodoxime screening of Escherichia coli and Klebsiella spp. by Vitek for detection of organisms producing extended-spectrum beta-lactamasesQ73366783
P433issue1
P921main subjectautomationQ184199
Escherichia coliQ25419
P304page(s)29-34
P577publication date2003-01-01
P1433published inDiagnostic Microbiology and Infectious DiseaseQ15763479
P1476titleComparison of BDPhoenix and VITEK2 automated antimicrobial susceptibility test systems for extended-spectrum beta-lactamase detection in Escherichia coli and Klebsiella species clinical isolates.
P478volume45

Reverse relations

cites work (P2860)
Q28076260A Review of SHV Extended-Spectrum β-Lactamases: Neglected Yet Ubiquitous
Q35765446Antibiotic combination as empirical therapy for extended spectrum Beta-lactamase.
Q41939169Comparison of Phoenix and VITEK 2 extended-spectrum-beta-lactamase detection tests for analysis of Escherichia coli and Klebsiella isolates with well-characterized beta-lactamases
Q33235526Detection and genotyping of SHV beta-lactamase variants by mass spectrometry after base-specific cleavage of in vitro-generated RNA transcripts
Q42799124Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures
Q39762100Direct comparison of the BD phoenix system with the MicroScan WalkAway system for identification and antimicrobial susceptibility testing of Enterobacteriaceae and nonfermentative gram-negative organisms
Q40282607Evaluation of the BD PHOENIX automated microbiology system for detection of methicillin resistance in coagulase-negative staphylococci
Q38478132Evaluation of the BD Phoenix automated microbiology system for identification and antimicrobial susceptibility testing of Enterobacteriaceae
Q38475591Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates
Q35090146Expert systems in clinical microbiology
Q43248345Extended-spectrum Beta-lactamase detection with different panels for automated susceptibility testing and with a chromogenic medium
Q24534999Extended-spectrum beta-lactamases: a clinical update
Q34159849Extended-spectrum ß-lactamases in gram negative bacteria
Q35558473Extended-spectrum β-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control
Q37809057Minor extended-spectrum β-lactamases.
Q35220822Two-center collaborative evaluation of performance of the BD phoenix automated microbiology system for identification and antimicrobial susceptibility testing of gram-negative bacteria
Q42130010Utility of the VITEK 2 Advanced Expert System for identification of extended-spectrum beta-lactamase production in Enterobacter spp.

Search more.